Vecuronium manufacturers & suppliers

Vecuronium

Form: Intravenous (IV) Injection

Strength: 10 mg/vial, 20 mg/vial

Reference Brands: Norcuron(US & EU)

Category: Critical Care

Vecuronium is a non-depolarizing neuromuscular blocking agent used to facilitate endotracheal intubation and provide skeletal muscle relaxation during surgery or mechanical ventilation. It is supplied as a lyophilized powder for intravenous use in strengths of 10 mg and 20 mg per vial. Vecuronium must be reconstituted before administration. In the US, brands include Norcuron (Organon/Merck), Hikma, and Sagent. In the EU, Norcuron, Vecuronium Hameln, and B. Braun are widely distributed. Vecuronium is a critical anesthetic and ICU drug commonly procured through pharma B2B supply chains for operating rooms, emergency departments, and intensive care units.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Glucagon

Strength: 1 mg lyophilized powder for reconstitution (IM/SC/IV)

Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) injection

Reference Brands: Glucagen®, Gvoke®,Baqsimi®(US); Glucagen® Hypokit(EU)

View Details
Insulin (Iv)

Strength: 100 units/mL (U-100) in 10 mL vials

Form: Intravenous (IV) solution

Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)

View Details
Flumazenil

Strength: 0.1 mg/mL in 5 mL or 10 mL vials

Form: Intravenous (IV) injection

Reference Brands: Romazicon®(US), Anexate®(EU)

View Details
Naloxone

Strength: 0.4 mg/mL in 1 mL/10 mL vials, 1 mg/mL in 2 mL prefilled syringes

Form: Intravenous (IV) injection/IM/SQ

Reference Brands: Narcan® (US); Narcan® (EU)

View Details

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.